Remove Compounding Remove Diabetes Remove Pharmaceutical Companies
article thumbnail

STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes

STAT

Pharmaceutical companies could be made to disclose prices and deals for products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord , Reuters reports. The first therapy that delays the onset of type 1 diabetes received approval from the U.S.

Diabetes 242
article thumbnail

STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more

STAT

… All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available  on the U.S. With all doses now listed as available, the FDA may soon pull it off the list, depending on its conversations with Novo about whether the company can sufficiently meet demand going forward.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

Pharmafile

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process.

article thumbnail

Neurology remains key therapeutic area for Japan pharma majors: GlobalData

Express Pharma

In the APAC region, several factors contribute to the increasing prevalence of neurological disorders, including ageing populations, lifestyle changes, and the rising incidence of risk factors such as hypertension and diabetes.” To cater to the unmet need, a number of Japan pharma companies have launched key assets.

article thumbnail

Leading innovators in glycoside hydrolase-based drug compositions for the pharmaceutical industry

Pharmaceutical Technology

Innovation S-curve for the pharmaceutical industry Glycoside hydrolase-based drug compositions is a key innovation area in pharmaceuticals Glycoside hydrolases are enzymes, which hydrolyse the glycosidic linkage between two or more carbohydrates or between carbohydrates and a non-carbohydrate moiety.

article thumbnail

Influence of 5G on Healthcare

Viseven

Insurance companies Insurance companies focus on promoting the health of their insured populations. For instance, using 5G-enabled patient monitoring devices for individuals with diabetes or cardiovascular conditions can save lives and prevent worsening symptoms, which, in turn, positively impacts insurance company’s bottom line.

article thumbnail

STAT+: Pharmalittle: Novo Nordisk sues spas, clinics over compounded Wegovy; top lobbyist leaves PhRMA

STAT

are illegally selling compounded versions of its medicines , STAT tells us. All three drugs are used to treat diabetes, although Wegovy was also approved by U.S. All three drugs are used to treat diabetes, although Wegovy was also approved by U.S. And all three drugs contain the same active ingredient, known as semaglutide.